ADVANCED MEDICAL SOLUTIONS GROUP PLC — AGM Information 2015

Apr 21, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9048K

Advanced Medical Solutions Grp PLC

21 April 2015

21 April 2015

Advanced Medical Solutions Group plc

("AMS" or the "Company")

Annual Report and Accounts for the year ended 31 December 2014 and Notice of AGM

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the surgical and advanced woundcare specialist company, is pleased to announce that in accordance with AIM Rules 20 and 26, the Annual Report and Financial Statements for the year ended 31 December 2014 were posted to shareholders today and are available on the Investor Relations section of the Company's website http://www.admedsol.com/Investor_Relations.

The notice of meeting convening the Annual General Meeting of the Company, which will be held on 21 May 2015 at 11 a.m. at 1 Cornhill, Gold Room, London, EC3V 3ND, was also posted to shareholders today and is available on the Company's website.

- Ends -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc Chris Meredith, Chief Executive Officer Mary Tavener, Group Finance Director	+44 (0) 1606 545508
Consilium Strategic Communications Mary-Jane Elliot / Jonathan Birt / Matthew Neal / Ivar Milligan	+44 (0) 20 3709 5700 AMS@consilium-comms.com
Investec Bank plc (NOMAD & Broker) Gary Clarence / Daniel Adams / Patrick Robb	+44 (0) 20 7597 5970

About Advanced Medical Solutions Group plc - see www.admedsol.com 

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Company has 472 employees.  For more information please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCUAAVRVBASUAR